INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 28, 2021 |
Director
Trans History: 466
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
| Jun 28, 2021 |
Director
Trans History: 466
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 9,349 |
| Jun 23, 2021 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 987,483 |
| Jun 23, 2021 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 5,845 |
| Jun 23, 2021 |
Director, President and Chief Scientific
Trans History: 673
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 211,585 |
| Jun 16, 2021 |
Director
Trans History: 466
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 5,000 |
| Jun 16, 2021 |
Director
Trans History: 466
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 9,349 |
| Jun 08, 2021 |
EVP Commercial
Trans History: 141
|
EVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 108 |
| May 18, 2021 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 5,787 |
| May 18, 2021 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 9,134 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.